Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Access qualified and experienced investigators to partner with on your clinical trials
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Citeline
24 Sep 2021
In 2017, Informa Pharma Intelligence took a deep dive into the clinical trial landscape in China over the previous 10 years, in a whitepaper entitled “Is China the Dark Horse in Clinical Development?”. That analysis showed that the number of trial starts in China had been trending upwards year-on-year and suggested that China was on course to become a formidable player within the pharma industry on a global stage.
Topic Clinical Trials
Biomedtracker, Datamonitor Healthcare
23 Sep 2021
Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.
Citeline Study Feasibility
22 Sep 2021
.hero-banner .content{ width: 100%; }
Biomedtracker, Datamonitor Healthcare
21 Sep 2021
Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.
Topic Drug Review Coronavirus
Scrip
20 Sep 2021
The highly anticipated Scrip Asia 100 is back, and there are a limited number of opportunities for you to be a part of it. Don’t miss your chance to connect to APAC market leaders with a high-profile sponsorship of this essential annual financial performance ranking of pharma companies headquartered in the APAC region.
Topic Business Strategies
Medtech Insight
By Ferdous Al-Faruque 14 Sep 2021
The US Medicare agency has proposed to withdraw a rule that would give temporary automatic coverage to breakthrough devices, stating the rule doesn’t meet its evidence threshold and could put patients at risk.
TrialScope Disclose
14 Sep 2021
Created by the European Medicines Agency (EMA). Stakeholders will use CTIS to: Submit and approve clinical trial applications (CTAs), Submit trial reports, results and notifications, Communicate centrally with the Member States Concerned (MSC) in the clinical trial
Topic Policy & Regulation Clinical Trials Clinical Trials Blog
Generics Bulletin
By David Wallace 14 Sep 2021
The Medicines Patent Pool has announced that the first shipments of dolutegravir under a fresh agreement covering upper-middle-income countries have reached Azerbaijan and Belarus.
Generics Bulletin
By Akriti Seth 14 Sep 2021
India’s Alkem has delivered a strong quarter with a boost in its domestic business on the back of “strong volume-led growth in the acute therapies and faster than market growth in chronic therapies.” However, the company saw a slight YoY decline in the US.
Medtech Insight
By Amanda Maxwell 14 Sep 2021
Gone are the days when notified bodies needed to promote themselves to gain business. Now industry is left struggling to find services ̶ and the EU regulatory outlook is becoming worrisome.
Thought leadership, Pharma Marketing Solutions
13 Sep 2021
Account-based marketing/engagement (ABM/ABE): this customer-centric, cross-functional approach to delivering clients and prospective clients superior marketing campaigns has become increasingly popular.
Topic Market Intelligence
HBW Insight
By David Ridley 13 Sep 2021
Amazon is becoming an increasingly important retail channel for the German wellness market. An analysis of best-selling categories, Omega 3, vitamin B and probiotic supplements, by Sempora Consulting suggests a mixture of exclusive and hybrid selling strategies can deliver results.
HBW Insight
By Malcolm Spicer 10 Sep 2021
Perrigo is the top potential marketer of the first OTC oral contraceptive in the US by acquiring HRA Pharma, which is preparing a switch NDA and earlier in 2021 gained UK regulatory approval for pharmacy sales of a progestin-only contraceptive, desogestrel.
In Vivo
By Ben Comer 07 Sep 2021
Treating opioid addiction successfully requires an individualized approach, and a lot of money. Executives at addiction treatment centers discuss existing barriers in the recovery pathway and the need to destigmatize addiction and mental health disorders.
Scrip
By Ian Haydock 06 Sep 2021
In this week's podcast edition of Five Must-Know Things: new US warnings for JAK inhibitors; strong new heart failure results for Jardiance; good head-to-head results for Pfizer in atopic dermatitis; US payers and drug exclusion lists; and a look ahead at key expected hematology launches.
Pink Sheet
27 Sep 2021
In Vivo
27 Sep 2021
Scrip
27 Sep 2021
Scrip
27 Sep 2021
Scrip
27 Sep 2021
Pink Sheet
27 Sep 2021
Generics Bulletin
27 Sep 2021
Generics Bulletin
24 Sep 2021
Scrip
24 Sep 2021
Scrip
24 Sep 2021
Pink Sheet
24 Sep 2021
HBW Insight
24 Sep 2021
Pink Sheet
24 Sep 2021
Generics Bulletin
24 Sep 2021
Pink Sheet
24 Sep 2021
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
14 Oct 2021 , 18:00
Awards
10 Nov 2021 , 18:00
Awards
19 Nov 2021 , 18:00
UK
Awards
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
